KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Change in Receivables (2021 - 2024)

Vir Biotechnology's Change in Receivables history spans 4 years, with the latest figure at $8.7 million for Q4 2024.

  • On a quarterly basis, Change in Receivables rose 142.57% to $8.7 million in Q4 2024 year-over-year; TTM through Dec 2024 was $6.5 million, a 1052.74% increase, with the full-year FY2024 number at $6.5 million, up 1052.74% from a year prior.
  • Change in Receivables hit $8.7 million in Q4 2024 for Vir Biotechnology, up from $54000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for VIR hit a ceiling of $680.1 million in Q4 2021 and a floor of -$883.8 million in Q2 2022.
  • Historically, Change in Receivables has averaged $778384.6 across 4 years, with a median of $54000.0 in 2024.
  • The widest YoY moves for Change in Receivables: up 142.57% in 2024, down 183.65% in 2024.
  • Tracing VIR's Change in Receivables over 4 years: stood at $680.1 million in 2021, then tumbled by 140.9% to -$278.2 million in 2022, then soared by 101.3% to $3.6 million in 2023, then skyrocketed by 142.57% to $8.7 million in 2024.
  • Business Quant data shows Change in Receivables for VIR at $8.7 million in Q4 2024, $54000.0 in Q3 2024, and -$2.7 million in Q2 2024.